Diagn. Microbiol. Infect. Dis. 2008, 62(4), 453-456.

Aspergillus fumigatus endocarditis of the mitral valve in a heart transplant recipient: a case report.

Diagn. Microbiol. Infect. Dis. 2008, 60(2), 193-195.

Fatal coinfection with Legionella pneumophila serogroup 8 and Aspergillus fumigatus.

J. Hosp. Infect. 2008, 68(4), 377-380.

Outbreaks of nosocomial candidiasis in France 1996-2006.

Bioorg. Med. Chem. Lett. 2008, 18(6), 1820-1824.

Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Bioorg. Med. Chem. Lett. 2008, 18(16), 4713-4715.

Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.

Bioorg. Med. Chem. 2008, 16(9), 4932-4953.

Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.

Toxicon 2008, 51(3), 398-405.

Effects of seawater on growth and gliotoxin excretion of marine strains of Aspergillus fumigatus Fres.

Fitoterapia, 2008, 79(1), 42-46.

Antileishmanial polyphenols from Garcinia vieillardii.

J. Enz. Inh. Med. Chem. 2008, 23(5), 629-640. 

Design, synthesis and evaluation of new 6-substituted-5-benzyloxy-4-oxo-4H-pyran-2-carboxamides as potential Src inhibitors.

J. Enz. Inh. Med. Chem. 2008, 23(5), 659-667.

Synthesis and immunosuppressive activity evaluation of substituted N-imidazolidin-2-ones and N-tetrahydropyrimidin-2(1H)-ones.

 J. Enz. Inh. Med. Chem.2008, 23(5), 686-695.

Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents.

J. Enz. Inh. Med. Chem. 2008, 23(5), 708-718.

Development of new antileishmanial drugs - current knowledge and future prospects.

J. Enz. Inh. Med. Chem. 2008, 23(5), 719-727.

Indole carboxamides inhibit bovine testes hyaluronidase at pH 7.0 and indole acetamides activate the enzyme at pH 3.5 by different mechanisms.

J. Enz. Inh. Med. Chem. 2008, 23(5), 728-738.

N-Pyridinyl(methyl)-indole-1- or 3-propanamides and propenamides acting as topical and systemic anti-inflammatory inhibitors.

Eur. J. Med. Chem., 2008, 43(7), 1469-1477.

Novel 9-oxo-thiazolo[5,4-f]quinazoline-2-carbonitrile derivatives as dual cyclin-dependent kinase 1 (CDK1) / glycogen synthase kinase-3 (GSK-3) inhibitors: synthesis, biological evaluation and molecular modeling studies.